Steven I Aronin MD
Senior Director, Clinical Development at Iterum Therapeutics
Join to View Full Profile
20 Research ParkwaySuite AOld Saybrook, CT 06475
Phone+1 860-661-4035
Dr. Aronin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Infectious Disease, 1994 - 1997
Yale New Haven Hospital1996- Yale-New Haven Medical CenterResidency, Internal Medicine, 1994
- Yale-New Haven Medical CenterInternship, Internal Medicine, 1991 - 1992
Ross University School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1994 - Present
CT State Medical License 1994 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014-2015
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2015
- Fellow (FACP) American College of Physicians, 2007
Clinical Trials
- Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI) Start of enrollment: 2017 Dec 15
Publications & Presentations
PubMed
- 5 citationsCharacterization of sulopenem antimicrobial activity usingtime-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods againstandisolates.Joshua M Maher, Michael D Huband, Jill M Lindley, Paul R Rhomberg, Steven I Aronin
Microbiology Spectrum. 2025-03-04 - 10 citationsA phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections.Michael W Dunne, Steven I Aronin, Anita F Das, Karthik Akinapelli, Jeanne D Breen
Clinical Microbiology and Infection. 2025-03-01 - Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation forIsolates.Sailaja Puttagunta, Steven I Aronin, Jeanna DiFranco-Fisher, Laura Koeth
Journal of Clinical Microbiology. 2023-07-20
Press Mentions
Iterum Therapeutics Announces Transition of Michael Dunne, M.D. To Strategic Advisor and Member of the Board of DirectorsDecember 23rd, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
